FDA Conflict Of Interest Waiver On Victoza Is Textbook Example For Supporters, Foes

Novo Nordisk's Victoza will get US advisory committee review June 20, and Tufts Medical Center's Marvin Konstam will serve on panel even though his institution participates in a trial for Janssen's Invokana.